tm logo
KANTARO
Live/Registered
REGISTERED

on 08 Mar 2022

Last Applicant/ Owned by

1460 Broadway

New York

NY

10036

Serial Number

88922034 filed on 18th May 2020

Registration Number

6667509 registered on 08th Mar 2022

in the Principal Register

Correspondent Address

Michelle A. Cooke

Michelle A. Cooke

2049 CENTURY PARK EAST, SUITE 1700

LOS ANGELES, CA 90067

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

KANTARO

Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnost Read More

Classification Information


Class [005]
Pharmaceutical Products


Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits primarily comprised of medical diagnostic reagents and assays, and also consisting of vessels, containers and implements being medical specimen collection and processing devices in the nature of tubes, swabs, bags, vials, laboratory bottles, cups, and laboratory pipettes for the collection and processing of blood, bodily fluids, biological and cellular samples and specimens and body tissue for performing serological and molecular tests, used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood, bodily fluids, biological and cellular samples and specimens and tissue for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical diagnostic test kits comprised of medical diagnostic assays, reagents, media, solutions in the nature of reagent solutions, substrate solutions, stop solutions, staining solutions, standard solutions and buffer solutions, buffers and diagnostic preparations for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring


First Use Date in General

14th Aug 2020

First Use Date in Commerce

28th Aug 2020

Mark Details


Serial Number

No 88922034

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 66680-031

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Mar 2022REGISTERED-PRINCIPAL REGISTER
01st Feb 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
31st Jan 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28th Jan 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
28th Jan 2022STATEMENT OF USE PROCESSING COMPLETE
13th Jan 2022USE AMENDMENT FILED
13th Jan 2022TEAS STATEMENT OF USE RECEIVED
13th Jul 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18th May 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18th May 2021PUBLISHED FOR OPPOSITION